Loading stock data…
Loading stock data…
US$5.63
Get one email when EOLS crosses your level. Checked every 15 minutes during market hours.
▼ -0.33 (-5.54%)down today
Could not load chart data. Please try again shortly.
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
28.5
OversoldAbove 70 can signal overbought; below 30, oversold.
MACD
-0.11
Bearish momentumMACD below its signal line (0.05).
50-day average
6.57
Price belowShort-term trend reference.
200-day average
5.90
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Drug Manufacturers - Specialty & Generic
Evolus is a performance beauty company specializing in injectable aesthetic products within the global cash-pay aesthetics market across the United States, Canada, Europe, and Australia. The company's flagship product, Jeuveau, is a proprietary botulinum toxin formulation designed to temporarily improve the appearance of moderate to severe frown lines in adults. Evolysse, its complementary portfolio offering, consists of injectable hyaluronic acid gels engineered with Cold-X Technology to addres…
www.evolus.com5 strong buy · 6 buy · 2 hold · 0 sell · 0 strong sell (13 analysts, 2026-07-01)
5 strong buy · 6 buy · 2 hold · 0 sell · 0 strong sell (13 analysts, 2026-06-01)
5 strong buy · 6 buy · 2 hold · 0 sell · 0 strong sell (13 analysts, 2026-05-01)
5 strong buy · 6 buy · 2 hold · 0 sell · 0 strong sell (13 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-04 | -0.12 | -0.05 | ✓ Beat |
| 2026-03-13 | 0.05 | 0.07 | ✓ Beat |
| 2026-03-03 | 0.04 | 0.01 | ✗ Miss |
| 2025-11-05 | -0.18 | -0.15 | ✓ Beat |
| 2025-08-05 | -0.09 | -0.26 | ✗ Miss |
| 2025-05-07 | -0.14 | -0.17 | ✗ Miss |
| 2025-03-04 | 0.02 | 0.01 | ✗ Miss |
| 2024-11-06 | -0.11 | -0.18 | ✗ Miss |
Companies in the same industry, via Finnhub